Figure 2.
A) Survival tree analysis in NER pathway in stages IIIB/IV NSCLC patients treated with first line cisplatin-based chemotherapy; B) Cox proportional model in stages IIIB/IV NSCLC patients treated with first line cisplatin-based chemotherapy based on the survival tree analysis in NER Pathway; C) Kaplan-Meier curves in stages IIIB/IV NSCLC patients treated with first line cisplatin-based chemotherapy based on survival tree analysis in NER Pathway for selected nodes.